Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother - 2The Following Huge Thing: 5 Progressive Tech New businesses
- 3Moving Wedding Objections for Paramount Functions
- 4Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
- 5Grasping Various Kinds of Local misdemeanors
- Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.'
- Brazil's ex-president Bolsonaro operated on for hernia
- Figure out How to Augment Your Rooftop Substitution Speculation
- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- Outside Lovers' Decision: Favored Climbing Rucksacks
- As world leaders enter climate talks, people in poverty have the most at stake
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- Building a Flourishing Business: Illustrations from Business people
- Taylor Swift's 'The End of an Era' docuseries: Everything you need to know, plus how to watch for less
